Expanded Access: Past, Present and Future Improvements

Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning

Expanded access is a program that provides patients with investigational medicinal products (IMP) for treatment purposes. These patients are often excluded from clinical trials but could still benefit from access to the drugs, biologics or medical devices being tested. While, in concept, expanded access represents a way to help more patients receive new and developing treatments, in reality, the process is complex and often misunderstood.

Download Position Paper

Related Education Resources.

All Resources

EU Clinical Trial Regulation 536/2014

Topic: Regulatory

Position Paper

Members

EAP 102: Part 2 of Introduction to EAP

Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning, Project Management, Strategic Planning

Presentation

Members

European Roadmap to Lift COVID-19 Containment

Topics: Health Care, Strategic Planning

White Paper

Free

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.

Join Renew